Jia Yang
Jia Yang has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Bijia Wang
Department of Neurology, Southwest Hospital Army Medical University (Third Military Medical University) Chongqing China
1 shared publication- Chen Liu
Department of Radiology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China
1 shared publication Cong Zhang
State Key Laboratory of Primate Biomedical ResearchInstitute of Primate Translational MedicineKunming University of Science and TechnologyKunmingYunnan 650500China
1 shared publicationCongwei Li
T Magnetic Resonance Imaging Translational Medical Center, Department of Radiology, Southwest Hospital Army Medical University (Third Military Medical University) Chongqing China
1 shared publicationFuqin Wang
Department of Radiology, Affiliated Hospital of Zunyi Medical University, Medical Imaging Center of Guizhou Province , Zunyi 563003 , China
1 shared publicationGuolin Ma
China‐Japan Friendship Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China
1 shared publication
Latest Publications
- 29 June 2026
- Published by Wiley in Movement Disorders
- Vol. 41 (10) , 2650-2661
Putamen Structural–Functional Decoupling as an Early‐Stage Candidate Imaging Marker for Motor Severity in Spinocerebellar Ataxia Type 3
Background: Spinocerebellar ataxia type 3 (SCA3) shows marked phenotypic heterogeneity and clinico‐radiological dissociation, wherein macrostructural atrophy often fails to fully account for clinical severity. Although structural and functional connectivity abnormalities are well recognized, their potential interaction and neurobiological mechanisms remain poorly understood. Objective: This study aimed to identify potential biomarkers for SCA3 by linking structural connectivity–functional connectivity ( SC – FC ) coupling to mitochondrial function, neurotransmitter distribution, and gene expression. Methods: This dual‐center study included discovery (117 SCA3, 163 healthy controls [HC]) and independent validation (24 SCA3, 48 HC) cohorts. [Correction added after first online publication on 8 July 2026: The number of healthy controls has been updated in the previous sentence.] Participants underwent multimodal 3 T magnetic resonance imaging (MRI) and clinical assessments (Scale for the Assessment and Rating of Ataxia [SARA]; International Cooperative Ataxia Rating Scale [ICARS]; Montreal Cognitive Assessment [MoCA]; Hamilton Depression Rating Scale [HAMD]). Regional and network‐level SC–FC coupling was quantified using multiple regression and compared across disease‐duration strata. Coupling alterations were spatially mapped to biological atlases (Allen Human Brain Atlas, MitoBrainMap, and positron emission tomography [PET]‐based neurotransmitter receptor atlases) using bootstrapped Spearman's correlations (false discovery rate [FDR]‐corrected). Gene enrichment analysis was implemented to characterize enriched biological pathways. Results: SCA3 patients exhibited significant, atrophy‐independent SC–FC decoupling in the bilateral dorsolateral putamen (dlPu), which correlated with ICARS scores. This decoupling pattern spatially aligned with mitochondrial complex II, 5‐HT2A/5‐HT4 receptors densities, and genes enriching for synaptic regulation and cellular homeostasis. Conclusions: By integrating SC–FC coupling with biological atlases, this study reveals the pathological underpinnings of clinico‐radiological dissociation in SCA3 and identifies dlPu decoupling as a promising early‐stage candidate imaging marker, providing an early and objective target for future neuroprotective trials. Trial Registration: Chinese Clinical Trial Registry (ChiCTR): 1800019901, 2000039434. © 2026 International Parkinson and Movement Disorder Society.
- 29 June 2026
- Published by Wiley in Movement Disorders
- Vol. 41 (10) , 2650-2661
Putamen Structural–Functional Decoupling as an Early‐Stage Candidate Imaging Marker for Motor Severity in Spinocerebellar Ataxia Type 3
Background: Spinocerebellar ataxia type 3 (SCA3) shows marked phenotypic heterogeneity and clinico‐radiological dissociation, wherein macrostructural atrophy often fails to fully account for clinical severity. Although structural and functional connectivity abnormalities are well recognized, their potential interaction and neurobiological mechanisms remain poorly understood. Objective: This study aimed to identify potential biomarkers for SCA3 by linking structural connectivity–functional connectivity ( SC – FC ) coupling to mitochondrial function, neurotransmitter distribution, and gene expression. Methods: This dual‐center study included discovery (117 SCA3, 163 healthy controls [HC]) and independent validation (24 SCA3, 48 HC) cohorts. [Correction added after first online publication on 8 July 2026: The number of healthy controls has been updated in the previous sentence.] Participants underwent multimodal 3 T magnetic resonance imaging (MRI) and clinical assessments (Scale for the Assessment and Rating of Ataxia [SARA]; International Cooperative Ataxia Rating Scale [ICARS]; Montreal Cognitive Assessment [MoCA]; Hamilton Depression Rating Scale [HAMD]). Regional and network‐level SC–FC coupling was quantified using multiple regression and compared across disease‐duration strata. Coupling alterations were spatially mapped to biological atlases (Allen Human Brain Atlas, MitoBrainMap, and positron emission tomography [PET]‐based neurotransmitter receptor atlases) using bootstrapped Spearman's correlations (false discovery rate [FDR]‐corrected). Gene enrichment analysis was implemented to characterize enriched biological pathways. Results: SCA3 patients exhibited significant, atrophy‐independent SC–FC decoupling in the bilateral dorsolateral putamen (dlPu), which correlated with ICARS scores. This decoupling pattern spatially aligned with mitochondrial complex II, 5‐HT2A/5‐HT4 receptors densities, and genes enriching for synaptic regulation and cellular homeostasis. Conclusions: By integrating SC–FC coupling with biological atlases, this study reveals the pathological underpinnings of clinico‐radiological dissociation in SCA3 and identifies dlPu decoupling as a promising early‐stage candidate imaging marker, providing an early and objective target for future neuroprotective trials. Trial Registration: Chinese Clinical Trial Registry (ChiCTR): 1800019901, 2000039434. © 2026 International Parkinson and Movement Disorder Society.
- Open Access
- 1 March 2023
- Published by SAGE Publications in Molecular Imaging
- Vol. 2023, 4223485
Optical and MRI Multimodal Tracing of Stem Cells In Vivo
Stem cell therapy has shown great clinical potential in oncology, injury, inflammation, and cardiovascular disease. However, due to the technical limitations of the in vivo visualization of transplanted stem cells, the therapeutic mechanisms and biosafety of stem cells in vivo are poorly defined, which limits the speed of clinical translation. The commonly used methods for the in vivo tracing of stem cells currently include optical imaging, magnetic resonance imaging (MRI), and nuclear medicine imaging. However, nuclear medicine imaging involves radioactive materials, MRI has low resolution at the cellular level, and optical imaging has poor tissue penetration in vivo. It is difficult for a single imaging method to simultaneously achieve the high penetration, high resolution, and noninvasiveness needed for in vivo imaging. However, multimodal imaging combines the advantages of different imaging modalities to determine the fate of stem cells in vivo in a multidimensional way. This review provides an overview of various multimodal imaging technologies and labeling methods commonly used for tracing stem cells, including optical imaging, MRI, and the combination of the two, while explaining the principles involved, comparing the advantages and disadvantages of different combination schemes, and discussing the challenges and prospects of human stem cell tracking techniques.
- 1 March 2023
- Published by SAGE Publications in Molecular Imaging
- Vol. 2023, 4223485
Open AccessOptical and MRI Multimodal Tracing of Stem Cells In Vivo
Stem cell therapy has shown great clinical potential in oncology, injury, inflammation, and cardiovascular disease. However, due to the technical limitations of the in vivo visualization of transplanted stem cells, the therapeutic mechanisms and biosafety of stem cells in vivo are poorly defined, which limits the speed of clinical translation. The commonly used methods for the in vivo tracing of stem cells currently include optical imaging, magnetic resonance imaging (MRI), and nuclear medicine imaging. However, nuclear medicine imaging involves radioactive materials, MRI has low resolution at the cellular level, and optical imaging has poor tissue penetration in vivo. It is difficult for a single imaging method to simultaneously achieve the high penetration, high resolution, and noninvasiveness needed for in vivo imaging. However, multimodal imaging combines the advantages of different imaging modalities to determine the fate of stem cells in vivo in a multidimensional way. This review provides an overview of various multimodal imaging technologies and labeling methods commonly used for tracing stem cells, including optical imaging, MRI, and the combination of the two, while explaining the principles involved, comparing the advantages and disadvantages of different combination schemes, and discussing the challenges and prospects of human stem cell tracking techniques.
- Open Access
- 29 November 2022
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 33 (10) , 5774-5782
Structural and functional changes in drug-naïve benign childhood epilepsy with centrotemporal spikes and their associated gene expression profiles
Benign epilepsy with centrotemporal spikes (BECTS) is a common pediatric epilepsy syndrome that has been widely reported to show abnormal brain structure and function. However, the genetic mechanisms underlying structural and functional changes remain largely unknown. Based on the structural and resting-state functional magnetic resonance imaging data of 22 drug-naïve children with BECTS and 33 healthy controls, we conducted voxel-based morphology (VBM) and fractional amplitude of low-frequency fluctuation (fALFF) analyses to compare cortical morphology and spontaneous brain activity between the 2 groups. In combination with the Allen Human Brain Atlas, transcriptome-neuroimaging spatial correlation analyses were applied to explore gene expression profiles associated with gray matter volume (GMV) and fALFF changes in BECTS. VBM analysis demonstrated significantly increased GMV in the right brainstem and right middle cingulate gyrus in BECTS. Moreover, children with BECTS exhibited significantly increased fALFF in left temporal pole, while decreased fALFF in right thalamus and left precuneus. These brain structural and functional alterations were closely related to behavioral and cognitive deficits, and the fALFF-linked gene expression profiles were enriched in voltage-gated ion channel and synaptic activity as well as neuron projection. Our findings suggest that brain morphological and functional abnormalities in children with BECTS involve complex polygenic genetic mechanisms.
- 29 November 2022
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 33 (10) , 5774-5782
Open AccessStructural and functional changes in drug-naïve benign childhood epilepsy with centrotemporal spikes and their associated gene expression profiles
Benign epilepsy with centrotemporal spikes (BECTS) is a common pediatric epilepsy syndrome that has been widely reported to show abnormal brain structure and function. However, the genetic mechanisms underlying structural and functional changes remain largely unknown. Based on the structural and resting-state functional magnetic resonance imaging data of 22 drug-naïve children with BECTS and 33 healthy controls, we conducted voxel-based morphology (VBM) and fractional amplitude of low-frequency fluctuation (fALFF) analyses to compare cortical morphology and spontaneous brain activity between the 2 groups. In combination with the Allen Human Brain Atlas, transcriptome-neuroimaging spatial correlation analyses were applied to explore gene expression profiles associated with gray matter volume (GMV) and fALFF changes in BECTS. VBM analysis demonstrated significantly increased GMV in the right brainstem and right middle cingulate gyrus in BECTS. Moreover, children with BECTS exhibited significantly increased fALFF in left temporal pole, while decreased fALFF in right thalamus and left precuneus. These brain structural and functional alterations were closely related to behavioral and cognitive deficits, and the fALFF-linked gene expression profiles were enriched in voltage-gated ion channel and synaptic activity as well as neuron projection. Our findings suggest that brain morphological and functional abnormalities in children with BECTS involve complex polygenic genetic mechanisms.